| __timestamp | Dynavax Technologies Corporation | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 11032000 | 580415000 |
| Thursday, January 1, 2015 | 4050000 | 1032336000 |
| Friday, January 1, 2016 | 11043000 | 1702177000 |
| Sunday, January 1, 2017 | 327000 | 2488652000 |
| Monday, January 1, 2018 | 8198000 | 3047597000 |
| Tuesday, January 1, 2019 | 35219000 | 4162821000 |
| Wednesday, January 1, 2020 | 46551000 | 6205683000 |
| Friday, January 1, 2021 | 439442000 | 7574400000 |
| Saturday, January 1, 2022 | 722683000 | 8930700000 |
| Sunday, January 1, 2023 | 232284000 | 9869200000 |
| Monday, January 1, 2024 | 11020100000 |
Unlocking the unknown
In the competitive world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Vertex Pharmaceuticals Incorporated has consistently outperformed Dynavax Technologies Corporation in annual revenue. Starting in 2014, Vertex's revenue was already 52 times greater than Dynavax's. By 2023, Vertex's revenue surged to nearly 10 billion, marking a 70% increase from 2014, while Dynavax saw a more modest growth, peaking at 723 million in 2022 before dropping to 232 million in 2023.
Vertex's robust growth can be attributed to its strong pipeline and successful commercialization of therapies, particularly in cystic fibrosis. In contrast, Dynavax's revenue trajectory reflects its strategic shifts and market challenges. The data highlights the importance of innovation and market adaptation in the biotech sector, where Vertex's strategic focus has clearly paid off.
Eli Lilly and Company vs Vertex Pharmaceuticals Incorporated: Examining Key Revenue Metrics
AstraZeneca PLC vs Vertex Pharmaceuticals Incorporated: Examining Key Revenue Metrics
Revenue Insights: Bristol-Myers Squibb Company and Vertex Pharmaceuticals Incorporated Performance Compared
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Zoetis Inc.
Vertex Pharmaceuticals Incorporated and Dr. Reddy's Laboratories Limited: A Comprehensive Revenue Analysis
Vertex Pharmaceuticals Incorporated vs Alkermes plc: Annual Revenue Growth Compared
Revenue Insights: Vertex Pharmaceuticals Incorporated and MorphoSys AG Performance Compared
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Who Generates More Revenue? argenx SE or Dynavax Technologies Corporation
Revenue Insights: Teva Pharmaceutical Industries Limited and Dynavax Technologies Corporation Performance Compared
Incyte Corporation vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Revenue Showdown: ACADIA Pharmaceuticals Inc. vs Dynavax Technologies Corporation